Synmosa Biopharma Corporation Logo

Synmosa Biopharma Corporation (4114)

TWSE

Currency in TWD
29.90
-0.35 (-1.16%)

Closed

Aug 25, 2026

Day's Range

29.90
30.25

52 wk Range

27.55
35.14

Overview - 4114 - Synmosa Biopharma Corporation

Key Statistics

Valuation

Enterprise Value

18.33B

P/E (Trailing)

‪19.02‬

P/E (Forward)

‪12.98‬

PEG Ratio

‪-0.98‬

Price / Sales (TTM)

‪2.31‬

Price / Book

‪1.89‬

EV / EBITDA

‪17.69‬

Profitability

Gross Margin

‪42.32%‬

Profit Margin

‪12.38%‬

Operating Margin

‪11.63%‬

Return on Assets

‪3.04%‬

Return on Equity

‪5.91%‬

Ownership

Shares Outstanding

543.35M

Float

413.84M

Held by Insiders

‪23.21%‬

Held by Institutions

‪4.34%‬

Price stats

50-Day Avg

‪29.54‬

200-Day Avg

‪29.35‬

Dividends

Payout Ratio

‪37.21%‬

Frequency

Annual

Analyst Consensus

Hold

1 analysts

Market Cap - 4114 - Synmosa Biopharma Corporation

Peers - 4114 - Synmosa Biopharma Corporation

Peer Comparison

Compared with companies in Drug Manufacturers - Specialty & Generic listed on TWSE.

Profile Summary - 4114 - Synmosa Biopharma Corporation

About

Synmosa Biopharma Corporation is a specialty pharmaceutical company headquartered in Taiwan, recognized for its comprehensive involvement in the healthcare sector. The company specializes in the research, development, manufacturing, and distribution of a wide array of pharmaceutical products, including prescription…

SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
Employees0
Full company profile

The information on this page is provided for general informational purposes only and is not investment advice.

Market data provided by Twelve Data. Charting by TradingView.

Last updated:

Stocks news

Track Global Markets in Real Time with UA Finance

Download the app now and access live financial data, expert analysis, and trusted economic news to follow stocks, forex, gold, and cryptocurrencies with ease.